Lumb R, Shaw D
Division of Clinical Microbiology, Institute of Medical and Veterinary Science, Adelaide, SA.
Med J Aust. 1992 Feb 17;156(4):286-7. doi: 10.5694/j.1326-5377.1992.tb139753.x.
To report a case of progressive disease caused by Mycobacterium bovis after BCG vaccination in a patient asymptomatically infected with the human immunodeficiency virus (HIV).
A 34-year-old white man about to commence employment as a developmental care worker had a BCG vaccination. Five months later, he had a positive result to a serological test for HIV antibody. Nine months after BCG vaccination, he presented with fever (38.7 degrees C), a large left axillary lymph node and a small left pleural effusion. The lymph node was biopsied and acid-fast bacilli observed in Ziehl-Neelsen stained smears. Culture grew Mycobacterium bovis (BCG).
He was successfully treated with isoniazid, rifampicin and ethambutol for a period of nine months.
BCG vaccination of asymptomatic HIV-positive patients is not recommended. The detection of those at risk for HIV infection before vaccination administration is essential. Self-exclusion based on information supplied to all potential recipients is likely to be the most effective method.
报告1例在无症状感染人类免疫缺陷病毒(HIV)的患者中,卡介苗接种后由牛分枝杆菌引起的进行性疾病病例。
一名即将开始从事发育护理工作的34岁白人男性接受了卡介苗接种。五个月后,他的HIV抗体血清学检测呈阳性。卡介苗接种九个月后,他出现发热(38.7摄氏度)、左侧腋窝一个大淋巴结和少量左侧胸腔积液。对淋巴结进行活检,在齐-尼氏染色涂片中观察到抗酸杆菌。培养物培养出牛分枝杆菌(卡介苗)。
他接受异烟肼、利福平及乙胺丁醇治疗九个月,治疗成功。
不建议对无症状HIV阳性患者进行卡介苗接种。在接种疫苗前检测有HIV感染风险的人群至关重要。基于向所有潜在接种者提供的信息进行自我排除可能是最有效的方法。